Page last updated: 2024-08-24

capecitabine and Diabetes Mellitus, Type 2

capecitabine has been researched along with Diabetes Mellitus, Type 2 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Al-Tassan, NA; Cheadle, JP; Escott-Price, V; Houlston, RS; Kaplan, R; Kerr, DJ; Kerr, R; Madi, A; Maughan, TS; Palles, C; Watts, K; Wills, C	1
Cunha, JE; Fernandes, Gdos S; Freitas, D; Hoff, PM	1
Farmer, A; Larsen, ME; Tarassenko, L; Weaver, A; Young, A	1

Reviews

1 review(s) available for capecitabine and Diabetes Mellitus, Type 2

Article	Year
Medical management of pancreatic adenocarcinoma. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2009, Volume: 9, Issue:3 Topics: Adenocarcinoma; Aged; Aging; Antineoplastic Agents; Black People; Capecitabine; Deoxycytidine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; DNA Mismatch Repair; Female; Fluorouracil; Gemcitabine; Helicobacter Infections; Helicobacter pylori; Humans; Male; Overweight; Palliative Care; Pancreatic Neoplasms; Risk Factors; Smoking	2009

Article

Year

Medical management of pancreatic adenocarcinoma.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2009, Volume: 9, Issue:3

Topics: Adenocarcinoma; Aged; Aging; Antineoplastic Agents; Black People; Capecitabine; Deoxycytidine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; DNA Mismatch Repair; Female; Fluorouracil; Gemcitabine; Helicobacter Infections; Helicobacter pylori; Humans; Male; Overweight; Palliative Care; Pancreatic Neoplasms; Risk Factors; Smoking

2009

Other Studies

2 other study(ies) available for capecitabine and Diabetes Mellitus, Type 2

Article	Year
Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome. International journal of cancer, 2022, 09-15, Volume: 151, Issue:6 Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cetuximab; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Fluorouracil; Genetic Variation; Genome-Wide Association Study; Hand-Foot Syndrome; Humans; Inflammation; Oxaliplatin; Psoriasis; Sialyltransferases	2022
Mobile health for drug dose optimisation. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2011, Volume: 2011 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Blood Glucose Self-Monitoring; Capecitabine; Deoxycytidine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Computer-Assisted; Female; Fluorouracil; Humans; Hypoglycemic Agents; Insulin; Neoplasms; Telemedicine; Treatment Outcome	2011

Article

Year

Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome.

International journal of cancer, 2022, 09-15, Volume: 151, Issue:6

Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cetuximab; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Fluorouracil; Genetic Variation; Genome-Wide Association Study; Hand-Foot Syndrome; Humans; Inflammation; Oxaliplatin; Psoriasis; Sialyltransferases

2022

Mobile health for drug dose optimisation.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2011, Volume: 2011

Topics: Administration, Oral; Antimetabolites, Antineoplastic; Blood Glucose Self-Monitoring; Capecitabine; Deoxycytidine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Computer-Assisted; Female; Fluorouracil; Humans; Hypoglycemic Agents; Insulin; Neoplasms; Telemedicine; Treatment Outcome

2011